Quique Bassat is an ICREA Research Professor at the Barcelona Institute for Global Health (ISGlobal). He has a degree in Medicine from the Universitat de Barcelona (UB, 1999), a specialization in pediatrics (UaB, 2004), and Masters in Tropical Medicine and International Health (UB, 2004) and Epidemiology (LSHTM, 2008). He obtained his PHD in the year 2009 (UB) with work on the treatment and clinical characterization of malaria in Africa. He was based for several years at the Centro de Investigação em Saúde de Manhiça (CISM), in Mozambique, where he currently conducts most of his research, although in recent years he has started projects in other countries, including Morocco, Papua New Guinea, Brazil or Bhutan. Since January 2024, he is the General director at ISGlobal. He has published over 525 scientific papers, and earned over 30M€ in competitive funding. He is a honorary fellow of the Spanish Pediatrics association.
Research interests
As a paediatrician, my research is based on the premise that there is no greater public health intervention than that which can reduce child mortality, particularly in poor contexts. I have worked in LMICs (Mozambique, Morocco, Papua New Guinea, India, Brazil and Bhutan) to understand and prevent malaria, pneumonia and other infectious diseases that most impact child survival. I’m interested in biomarkers of host response as diagnostic and prognostic tools to help risk stratify children and better prioritize care. My research has included the clinical development of malaria vaccines and new or repurposed drugs/drug-based strategies for malaria and other life-threatening infections. To improve the poor existing data on the causes of child mortality. we have developed and implemented in resource constrained settings the minimally invasive autopsy (MIA) method for mortality surveillance purposes, now widely deployed. I enjoy approaching innovation for the purposes of solving global health
Selected publications
- Balanza N, Francis CK, Crowley VM, et al. 2024, 'Neurofilament Light Chain as a Biomarker of Neuronal Damage in Children With Malaria', Journal Of Infectious Diseases, 229, 1, 183–188.
- Ogbuanu, IU et al. 2024, 'Burden of child mortality from malaria in high endemic areas: Results from the CHAMPS network using minimally invasive tissue sampling', Journal of infection, 88 - 3 - 106107.
- Ajanovic, S et al. 2024, 'Neurological Symptoms and Cause of Death Among Young Children in Low- and Middle-Income Countries', Jama network open, 7 - 9 - e2431512.
- Mahtab, S et al. 2024, 'Etiologies and comorbidities of meningitis deaths in children under 5 years in high-mortality settings: Insights from the CHAMPS Network in the post-pneumococcal vaccine era', Journal of infection, 89 - 6 -106341.
Selected research activities
During 2024, I was granted different prizes and recognition's, including becoming Honorary Fellow of the Spanish pediatric Association, or winning the Premi Josep Barrio (infectologia) [Catalan Society of Microbiology and Infectious Diseases], for the paper Bassat Q et al, Causes of Death Among Infants and Children in the Child Health and Mortality Prevention Surveillance (CHAMPS) Network. JAMA Netw Open. 2023 Jul 3;6(7):e2322494.
I was also honored by being elected as the European Parliament representative to the board of the ECDC (European Centers for Disease Control).
Finally, in 2024, I published 45 papers (according to Pubmed), but the 4 highlighted ones are, in my opinion, important contributions to the international literature of pediatric infectious diseases and cause of death in low income settings, as well as the science of prognostic biomarkers.